Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 7Unknown 4Suspended 1

Sponsor Class

NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Inflammatory Breast Neoplasms 1

Interventions

Radiotherapy 106Cyclophosphamide 97Cisplatin 75Carboplatin 66Fluorouracil 64Etoposide 61Doxorubicin 60Chemotherapy, Adjuvant 60Vincristine 56Peripheral Blood Stem Cell Transplantation 48Filgrastim 47Paclitaxel 46Gemcitabine 44Cytarabine 41Neoadjuvant Therapy 40Leucovorin 40Docetaxel 35Melphalan 31Oxaliplatin 29Methotrexate 29Ifosfamide 25Gene Expression Profiling 25Amplified Fragment Length Polymorphism Analysis 24Immunohistochemistry 23Dexamethasone 22Irinotecan 21aldesleukin 20Prednisolone 20Interferon-alpha 20Tamoxifen 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × NIH × CMF regimen × Clear all
NCT00012311 2014-01-06

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Breast

Breast Neoplasms

NCT00002498 2013-12-18

Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Breast

Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
300 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00033683 2009-02-09

Combination Chemotherapy in Treating Women With Resected Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡